Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Regulação e direito · 02/10/20091 min de leitura
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock
Tradução automática local · Idioma original da fonte
Resumo
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/231,348 entitled "Novel Use and Method of Rapamycin to Treat Toxic Shock," filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Idioma original da fonte: Federal Register — All DocumentsAbrir o comunicado original →